Progress in Pediatric Cardiology
Volume 21, Issue 2 , Pages 193-199 , March 2006

The use of polymer based scaffolds in tissue-engineered heart valves

  • Peter Fong

      Affiliations

    • Department of Pediatric Surgery, Yale School of Medicine, FMB 132 333 Cedar Street, New Haven, CT 06520, USA
    • Department of Biomedical Engineering, Yale University, 15 Prospect Street, Becton Center 225, New Haven, CT 06511, USA
    • Tel.: +203 785 2701; fax: +203 785 3820.
    • Tel.: +203 432 4262; fax: +203 432 0300.
    • ,
  • Toshiharu Shin'oka

      Affiliations

    • Department of Cardiovascular Surgery, The Heart Institute of Japan, Tokyo Women's Medical University, Tokyo, Japan
    • ,
  • Reynold I. Lopez-Soler

      Affiliations

    • Department of Pediatric Surgery, Yale School of Medicine, FMB 132 333 Cedar Street, New Haven, CT 06520, USA
    • Tel.: +203 785 2701; fax: +203 785 3820.
    • ,
  • Christopher Breuer

      Affiliations

    • Department of Pediatric Surgery, Yale School of Medicine, FMB 132 333 Cedar Street, New Haven, CT 06520, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 203 785 2701; fax: +1 203 785 3820.

References 

  1. Schoen FJ, Levy RJ. Founder's award, 25th annual meeting of the society for biomaterials, perspectives. Providence, RI, April 28–May 2, 1999. Tissue heart valves: current challenges and future research perspectives. J Biomed Mater Res. 1999;47:439–465
  2. Breuer CK, Mettler BA, Anthony T, Sales VL, Schoen FJ, Mayer JE. Application of tissue-engineering principles toward the development of a semilunar heart valve substitute. Tissue Eng. 2004;10:1725–1736
  3. Bloomfield P, Wheatley DJ, Prescott RJ, Miller HC. Twelve-year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses. N Engl J Med. 1991;324:573–579
  4. Hammermeister KE, Sethi GK, Henderson WG, Oprian C, Kim T, Rahimtoola S. A comparison of outcomes in men 11 years after heart-valve replacement with a mechanical valve or bioprosthesis. Veterans affairs cooperative study on valvular heart disease. N Engl J Med. 1993;328:1289–1296
  5. Grunkemeier GL, Rahimtoola SH. Artificial heart valves. Annu Rev Med. 1990;41:251–263
  6. Jamieson WR. Modern cardiac valve devices-bioprostheses and mechanical prostheses: state of the art. J Card Surg. 1993;8:89–98
  7. Turina J, Hess OM, Turina M, Krayenbuehl HP. Cardiac bioprostheses in the 1990s. Circulation. 1993;88:775–781
  8. Vongpatanasin W, Hillis LD, Lange RA. Prosthetic heart valves. N Engl J Med. 1996;335:407–416
  9. Schoen FJ. Pathologic considerations in replacement heart valves and other cardiovascular prosthetic devices. Monogr Pathol. 1995;37:194–222
  10. Edmunds LH, Clark RE, Cohn LH, Grunkemeier GL, Miller DC, Weisel RD. Guidelines for reporting morbidity and mortality after cardiac valvular operations. Ad Hoc Liaison Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity of the American Association for Thoracic Surgery and the Society of Thoracic Surgeons. J Thorac Cardiovasc Surg. 1996;112:708–711
  11. Langer R, Vacanti JP. Tissue engineering. Science. 1993;260:920–926
  12. Hsu SH, Whu SW, Hsieh SC, Tsai CL, Chen DC, Tan TS. Evaluation of chitosan-alginate-hyaluronate complexes modified by an RGD-containing protein as tissue-engineering scaffolds for cartilage regeneration. Artif Organs. 2004;28:693–703
  13. Sheridan MH, Shea LD, Peters MC, Mooney DJ. Bioabsorbable polymer scaffolds for tissue engineering capable of sustained growth factor delivery. J Control Release. 2000;64:91–102
  14. Teebken OE, Bader A, Steinhoff G, Haverich A. Tissue engineering of vascular grafts: human cell seeding of decellularised porcine matrix. Eur J Vasc Endovasc Surg. 2000;19:381–386
  15. Wilson GJ, Courtman DW, Klement P, Lee JM, Yeger H. Acellular matrix: a biomaterials approach for coronary artery bypass and heart valve replacement. Ann Thorac Surg. 1995;60:S353–S358
  16. Zund G, Breuer CK, Shinoka T, et al. The in vitro construction of a tissue engineered bioprosthetic heart valve. Eur J Cardio-thorac Surg. 1997;11:493–497
  17. Wang Y, Ameer GA, Sheppard BJ, Langer R. A tough biodegradable elastomer. Nat Biotechnol. 2002;20:602–606
  18. Booth C, Korossis SA, Wilcox HE, et al. Tissue engineering of cardiac valve prostheses: I. Development and histological characterization of an acellular porcine scaffold. J Heart Valve Dis. 2002;11:457–462
  19. Shinoka T, Ma PX, Shum-Tim D, et al. Tissue-engineered heart valves. Autologous valve leaflet replacement study in a lamb model. Circulation. 1996;94:II164–II168
  20. Shinoka T, Breuer CK, Tanel RE, et al. Tissue engineering heart valves: valve leaflet replacement study in a lamb model. Ann Thorac Surg. 1995;60:S513–S516
  21. Shinoka T, Shum-Tim D, Ma PX, et al. Creation of viable pulmonary artery autografts through tissue engineering. J Thorac Cardiovasc Surg. 1998;115:536–545[discussion 545–6]
  22. Sodian R, Hoerstrup SP, Sperling JS, et al. Tissue engineering of heart valves: in vitro experiences. Ann Thorac Surg. 2000;70:140–144
  23. Sodian R, Hoerstrup SP, Sperling JS, et al. Evaluation of biodegradable, three-dimensional matrices for tissue engineering of heart valves. Asaio J. 2000;46:107–110
  24. Sodian R, Loebe M, Hein A, et al. Application of stereolithography for scaffold fabrication for tissue engineered heart valves. Asaio J. 2002;48:12–16
  25. Hoerstrup SP, Sodian R, Daebritz S, et al. Functional living trileaflet heart valves grown in vitro. Circulation. 2000;102:III44–III49
  26. Stock UA, Mayer JE. Valves in development for autogenous tissue valve replacement. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 1999;2:51–64
  27. Perry TE, Kaushal S, Nasseri B, et al. Peripheral blood as a cell source for tissue engineering heart valves. Circulation. 2002;104:
  28. Sodian R, Hoerstrup SP, Sperling JS, et al. Early in vivo experience with tissue-engineered trileaflet heart valves. Circulation. 2000;102:III22–III29
  29. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143–147
  30. Sutherland FWH, Perry TE, Sherwood M, et al. Bone marrow derived pulmonary valve substitutes display favorable hemodynamic function in vivo. In: Abstract Presented at American Heart Association, Orlando, FL. 2002;
  31. Kaushal S, Amiel GE, Guleserian KJ, et al. Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo. Nat Med. 2001;7:1035–1040
  32. Guleserian KJ, Sander TL, Rabkin E, et al. Human umbilical cord blood derived endothelial progenitor cells (HUCB-EPCs); A novel source for cardiovascular tissue engineering. Circulation. 2001;104:
  33. Gloeckner DC, Billiar KL, Sacks MS. Effects of mechanical fatigue on the bending properties of the porcine bioprosthetic heart valve. Asaio J. 1999;45:59–63
  34. Engelmayr GC, Hildebrand DK, Sutherland FW, Mayer JE, Sacks MS. A novel bioreactor for the dynamic flexural stimulation of tissue engineered heart valve biomaterials. Biomaterials. 2003;24:2523–2532
  35. Stock UA, Wiederschain D, Kilroy SM, et al. Dynamics of extracellular matrix production and turnover in tissue engineered cardiovascular structures. J Cell Biochem. 2001;81:220–228
  36. Sutherland FW, Perry TE, Nasseri BA, et al. Advances in the mechanisms of cell delivery to cardiovascular scaffolds: comparison of two rotating cell culture systems. Asaio J. 2002;48:346–349
  37. Mitka M. Tissue engineering approaches utility. Jama. 2000;284:2582–2583
  38. Nasseri BA, Pomerantseva I, Kaazempur-Mofrad MR, et al. Dynamic rotational seeding and cell culture system for vascular tube formation. Tissue Eng. 2003;9:291–299
  39. Stock UA, Mayer JE. Tissue engineering of cardiac valves on the basis of PGA/PLA Co-polymers. J Long Term Eff Med Implants. 2001;11:249–260
  40. Rabkin E, Hoerstrup SP, Aikawa M, Mayer JE, Schoen FJ. Evolution of cell phenotype and extracellular matrix in tissue-engineered heart valves during in-vitro maturation and in-vivo remodeling. J Heart Valve Dis. 2002;11:308–314[discussion 314]
  41. Taylor PM, Allen SP, Dreger SA, Yacoub MH. Human cardiac valve interstitial cells in collagen sponge: a biological three-dimensional matrix for tissue engineering. J Heart Valve Dis. 2002;11:298–306[discussion 306–7]
  42. Sutherland FW, Perry TE, Yu Y, et al. From stem cells to viable autologous semilunar heart valve. Circulation. 2005;111:2783–2791
  43. Flanagan TC, Pandit A. Living artificial heart valve alternatives: a review. Eur Cell Mater. 2003;6:28–45[discussion 45]
  44. Maish MS, Hoffman-Kim D, Krueger PM, Souza JM, Harper JJ, Hopkins RA. Tricuspid valve biopsy: a potential source of cardiac myofibroblast cells for tissue-engineered cardiac valves. J Heart Valve Dis. 2003;12:264–269
  45. Shinoka T, Shum-Tim D, Ma PX, et al. Tissue-engineered heart valve leaflets: does cell origin affect outcome?. Circulation. 1997;96:II-102–II-107
  46. Mayer JE, Shin'oka T, Shum-Tim D. Tissue engineering of cardiovascular structures. Curr Opin Cardiol. 1997;12:528–532
  47. Hoerstrup SP, Kadner A, Breymann C, et al. Living, autologous pulmonary artery conduits tissue engineered from human umbilical cord cells. Ann Thorac Surg. 2002;74:46–52[discussion 52]
  48. Kadner A, Hoerstrup SP, Zund G, et al. A new source for cardiovascular tissue engineering: human bone marrow stromal cells. Eur J Cardiothorac Surg. 2002;21:1055–1060
  49. Sodian R, Sperling JS, Martin DP, Stock U, Mayer JE, Vacanti JP. Tissue engineering of a trileaflet heart valve-early in vitro experiences with a combined polymer. Tissue Eng. 1999;5:489–494
  50. Vacanti JP, Morse MA, Saltzman WM, Domb AJ, Perez-Atayde A, Langer R. Selective cell transplantation using bioabsorbable artificial polymers as matrices. J Pediatr Surg. 1988;23:3–9
  51. Hoerstrup SP, Sodian R, Sperling JS, Vacanti JP, Mayer JE. New pulsatile bioreactor for in vitro formation of tissue engineered heart valves. Tissue Eng. 2000;6:75–79
  52. Sodian R, Lemke T, Loebe M, et al. New pulsatile bioreactor for fabrication of tissue-engineered patches. J Biomed Mater Res. 2001;58:401–405
  53. Jockenhoevel S, Zund G, Hoerstrup SP, Schnell A, Turina M. Cardiovascular tissue engineering: a new laminar flow chamber for in vitro improvement of mechanical tissue properties. Asaio J. 2002;48:8–11
  54. Dohmen PM, Lembcke A, Hotz H, Kivelitz D, Konertz WF. Ross operation with a tissue-engineered heart valve. Ann Thorac Surg. 2002;74:1438–1442
  55. Simon P, Kasimir MT, Seebacher G, et al. Early failure of the tissue engineered porcine heart valve SYNERGRAFT in pediatric patients. Eur J Cardiothorac Surg. 2003;23:1002–1006[discussion 1006]
  56. Matsumura G, Hibino N, Ikada Y, Kurosawa H, Shin'oka T. Successful application of tissue engineered vascular autografts: clinical experience. Biomaterials. 2003;24:2303–2308
  57. Isomatsu Y, Shin'oka T, Matsumura G, et al. Extracardiac total cavopulmonary connection using a tissue-engineered graft. J Thorac Cardiovasc Surg. 2003;126:1958–1962
  58. Naito Y, Imai Y, Shin'oka T, et al. Successful clinical application of tissue-engineered graft for extracardiac Fontan operation. J Thorac Cardiovasc Surg. 2003;125:419–420
  59. Matsumura G, Miyagawa-Tomita S, Shin'oka T, Ikada Y, Kurosawa H. First evidence that bone marrow cells contribute to the construction of tissue-engineered vascular autografts in vivo. Circulation. 2003;108:1729–1734

☆ This work was supported by generous grants from the American Surgical Association Foundation and the American Pediatric Surgical Foundation.

PII: S1058-9813(05)00085-8

doi: 10.1016/j.ppedcard.2005.11.007

Progress in Pediatric Cardiology
Volume 21, Issue 2 , Pages 193-199 , March 2006

Article Tools

* Image Usage & Resolution